Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 26 May 2026

Tuesday, 26 May 2026

Ceisteanna (1139)

Ken O'Flynn

Ceist:

1139. Deputy Ken O'Flynn asked the Minister for Health if any hospitals, hospital groups, or specialist neurology centres currently facilitate access to omaveloxolone (skyclarys) through named-patient arrangements, manufacturer-supported supply, or exceptional approval mechanisms outside PCRS reimbursement pathways. [38854/26]

Amharc ar fhreagra

Freagraí scríofa

This PQ has been referred to the HSE for direct reply to the Deputy as it relates to an operational matter.

Roinn